title: Acute myocardial infarction complicated by ventricular standstill terminated by thrombolysis and transcutaneous pacing.
abstract: Although the overall need for emergency pacing following AMI has reduced with the wide spread use of thrombolysis the availability of transcutaneous pacing offers an emergency non-invasive strategy to optimise circulation following CHB or ventricular standstill. Transcutaneous pacing also facilitates the safe instigation of thrombolytic therapy to achieve reperfusion of the conduction system following AMI.
authors.affiliation: Department of EMC&R, Durban University of Technology, South Africa. Nicholas.castle@ntlworld.com
authors.forename: Nick
authors.initials: N
authors.lastname: Castle
authors.forename: Crispin
authors.initials: C
authors.lastname: Porter
authors.forename: Beverley
authors.initials: B
authors.lastname: Thompson
mesh_terms: D000328:Adult; D002304:Cardiac Pacing, Artificial / Q000379:methods*; D004359:Drug Therapy, Combination; D004562:Electrocardiography; D017984:Enoxaparin / Q000008:administration & dosage; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D005500:Follow-Up Studies; D006327:Heart Block / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D006339:Heart Rate; D006801:Humans; D007275:Injections, Intravenous; D009203:Myocardial Infarction / Q000150:complications* / Q000503:physiopathology; D000077785:Tenecteplase; D015912:Thrombolytic Therapy / Q000379:methods*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage
chemical_list: D017984:Enoxaparin; D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator; D000077785:Tenecteplase